Randomized trials evaluate optimal atropine dosing for myopia control

A meta-analysis of randomized clinical trials found that atropine slowed myopia progression in children across a range of concentrations, though benefits appeared to level off at higher doses while side effects became more common. Researchers reviewed 33 randomized clinical trials involving 6,301 children aged 4 to 18 years that compared...